Trigran Investments’s Avanos Medical AVNS Stock Holding History

Trigran Investments’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-95,540	Closed	-$1.34M	–	18
2026 Q1	$1.34M	Buy	+95,540	New	+$1.29M	0.32%	16

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Trigran Investments's AVNS Position: Q2 2026 in Review

Trigran Investments sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 95,540 shares — an estimated $1.34M sold.

Trigran Investments first reported a position in AVNS in Q1 2026 and held it in 1 quarter. The position peaked at $1.34M in Q1 2026. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Trigran Investments reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
Trigran Investments sold 95,540 Avanos Medical shares in Q2 2026, an estimated $1.34M.
Trigran Investments first reported a position in Avanos Medical in Q1 2026 and held it in 1 quarter.
Trigran Investments's Avanos Medical position peaked at $1.34M in Q1 2026.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Trigran Investments's 13F filing for Q2 2026, filed 12 Aug 2026.